Royal college

RCSI Bahrain Nursing Programmes receive Saudi Accreditation

Retrieved on: 
Sunday, January 29, 2023

BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.

Key Points: 
  • BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.
  • The Ministry of Education in Saudi Arabia has awarded accreditation to RCSI Bahrain's nursing undergraduate and postgraduate programmes.
  • As a result, Saudi nationals interested in pursuing a career in nursing as well as a postgraduate nursing degree will now be able to complete their qualification from RCSI Bahrain and subsequently join the nursing workforce in their home country or abroad.
  • RCSI Bahrain looks forward to supporting the advancement of the nursing workforce in support of improved health outcomes for all patients and people in the Gulf Cooperation Countries.

RCSI Bahrain Nursing Programmes receive Saudi Accreditation

Retrieved on: 
Sunday, January 29, 2023

BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.

Key Points: 
  • BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.
  • The Ministry of Education in Saudi Arabia has awarded accreditation to RCSI Bahrain's nursing undergraduate and postgraduate programmes.
  • As a result, Saudi nationals interested in pursuing a career in nursing as well as a postgraduate nursing degree will now be able to complete their qualification from RCSI Bahrain and subsequently join the nursing workforce in their home country or abroad.
  • RCSI Bahrain looks forward to supporting the advancement of the nursing workforce in support of improved health outcomes for all patients and people in the Gulf Cooperation Countries.

Design teams at PA Consulting are honored with six Good Design Awards

Retrieved on: 
Thursday, January 26, 2023

NEW YORK, Jan. 26, 2023 /PRNewswire/ -- PA Consulting (PA), the consultancy that's bringing ingenuity to life, celebrates along with its clients, six Good Design Awards .

Key Points: 
  • NEW YORK, Jan. 26, 2023 /PRNewswire/ -- PA Consulting (PA), the consultancy that's bringing ingenuity to life, celebrates along with its clients, six Good Design Awards .
  • Industrial Award: The team at Design Partners (part of PA Consulting) was honored with the Industrial award for their work with Picavi Smart Mount .
  • Household award: Cricut worked with Design Partners (part of PA Consulting) for their expertise in design and engineering to create the Cricut Hat Press .
  • Richard Watson, design lead at PA Consulting, says: "These awards are a testament to the exceptional work that our teams and clients are doing together.

MELANIE GRANT APPOINTED AS NEW EXECUTIVE DIRECTOR OF THE RESPONSIBLE JEWELLERY COUNCIL

Retrieved on: 
Monday, January 23, 2023

Melanie Grant has been a journalist for over 20 years -- having worked at The Times, The Financial Times, The Independent, The Guardian, The BBC and -- until 2022 -- The Economist, where she was luxury editor of 1843 Magazine, its lifestyle sister publication. She worked at The Economist for 16 years as jewellery editor and picture editor and took a sabbatical to write her first book on the jewel as art, entitled Coveted: Art and Innovation in High Jewellery, published by Phaidon in October 2020.  She has been on a mission for the last decade to dismantle boundaries between art forms so that jewellery is considered equal to fine art.

Key Points: 
  • LONDON, Jan. 23, 2023 /PRNewswire/ -- The Responsible Jewellery Council (RJC), the world's leading sustainability standard setting organisation for the jewellery and watch industry, today appointed Melanie Grant as its new executive director.
  • A celebrated thinker, writer and curator, Ms. Grant brings more than 20 years of experience in the watch and jewellery industry's biggest and most influential outlets.
  • David Bouffard, Chairman of the Board of the RJC said, "On behalf of the board, staff and all our members, I am proud to welcome Melanie as our new executive director.
  • Melanie Grant, RJC Executive Director, is available starting today for interview requests.

MELANIE GRANT APPOINTED AS NEW EXECUTIVE DIRECTOR OF THE RESPONSIBLE JEWELLERY COUNCIL

Retrieved on: 
Monday, January 23, 2023

Melanie Grant has been a journalist for over 20 years -- having worked at The Times, The Financial Times, The Independent, The Guardian, The BBC and -- until 2022 -- The Economist, where she was luxury editor of 1843 Magazine, its lifestyle sister publication. She worked at The Economist for 16 years as jewellery editor and picture editor and took a sabbatical to write her first book on the jewel as art, entitled Coveted: Art and Innovation in High Jewellery, published by Phaidon in October 2020.  She has been on a mission for the last decade to dismantle boundaries between art forms so that jewellery is considered equal to fine art.

Key Points: 
  • LONDON, Jan. 23, 2023 /PRNewswire/ -- The Responsible Jewellery Council (RJC), the world's leading sustainability standard setting organisation for the jewellery and watch industry, today appointed Melanie Grant as its new executive director.
  • A celebrated thinker, writer and curator, Ms. Grant brings more than 20 years of experience in the watch and jewellery industry's biggest and most influential outlets.
  • David Bouffard, Chairman of the Board of the RJC said, "On behalf of the board, staff and all our members, I am proud to welcome Melanie as our new executive director.
  • Melanie Grant, RJC Executive Director, is available starting today for interview requests.

The Canadian Vaping Association cautions the Government of Quebec on its proposed vape tax

Retrieved on: 
Friday, February 10, 2023

Vaping being more affordable than smoking was previously among the incentives for smokers to switch to a less harmful product.

Key Points: 
  • Vaping being more affordable than smoking was previously among the incentives for smokers to switch to a less harmful product.
  • This tax eliminates that incentive and punishes people who smoke for trying to end their addiction to combustible tobacco and improve their health.
  • The excise tax prioritizes short-term financial gains over longer-term improvements to public health and reductions in health care costs.
  • The Canadian Vaping Association implores the Government of Quebec to reconsider a provincial vape tax.

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer

Retrieved on: 
Monday, February 6, 2023

“During a 25-year tenure in the industry, Dr. Morris has demonstrated a proven track record of advancing novel oncology product candidates from clinical development through global regulatory approvals,” said Stephen Hurly, president and chief executive officer of LAVA Therapeutics.

Key Points: 
  • “During a 25-year tenure in the industry, Dr. Morris has demonstrated a proven track record of advancing novel oncology product candidates from clinical development through global regulatory approvals,” said Stephen Hurly, president and chief executive officer of LAVA Therapeutics.
  • Dr. Morris is a medical oncologist with over 25 years of oncology drug development experience working with global biotech and pharmaceutical companies and managing numerous drug approvals.
  • Most recently, he was the chief medical officer for Celyad Oncology, a biotechnology company focused on the research and discovery of chimeric antigen receptor T cell (CAR T) therapies for cancer.
  • Dr. Morris also served as chief medical officer of Radius Health and held leadership positions at PsiOxus Therapeutics, ImmunoGen and Allos Therapeutics, where he contributed to all phases of development for solid and hematological tumor indications.

Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP

Retrieved on: 
Tuesday, January 10, 2023

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Murray W. Stewart, D.M., F.R.C.P., has been appointed to the Company’s Board of Directors. Following the appointment of Dr. Stewart, the Amarin Board will be made up of approximately 70 percent of new independent directors who were named to the Board over the last 12 months.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Murray W. Stewart, D.M., F.R.C.P., has been appointed to the Company’s Board of Directors.
  • Following the appointment of Dr. Stewart, the Amarin Board will be made up of approximately 70 percent of new independent directors who were named to the Board over the last 12 months.
  • “As we focus on launching in Europe and diversifying our product portfolio, adding Dr. Stewart to our Board brings exceptional expertise in cardiometabolic research and clinical development,” said Per Wold-Olsen, Chairman of the Board of Directors, Amarin.
  • As part of the Company’s focus on stronger corporate governance, Amarin has named six new members to the Company’s board of directors over the last 12 months, including Dr. Murray Stewart.

Acadia Pharmaceuticals Appoints Doug Williamson, M.D., as Executive Vice President, Head of Research and Development

Retrieved on: 
Monday, January 9, 2023

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today the appointment of Dr. Doug Williamson as Executive Vice President, Head of Research and Development (R&D).

Key Points: 
  • Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today the appointment of Dr. Doug Williamson as Executive Vice President, Head of Research and Development (R&D).
  • Dr. Williamson will lead research and development at Acadia and will serve as a member of the company’s Executive Management Committee, reporting to Steve Davis, Chief Executive Officer of Acadia.
  • “We are excited to announce Doug’s appointment,” said Steve Davis, Acadia’s Chief Executive Officer.
  • Dr. Williamson brings more than 20 years of research, development, and commercial experience to his new role.

FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia

Retrieved on: 
Monday, January 9, 2023

“We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.

Key Points: 
  • “We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.
  • “Australia is a hotbed for clinical stage biotech companies, and our drug development programs will be able to take advantage of facilities offered by various government incentives in Australia,” added Mr. Saeed.
  • Chataway, Dhanda and Lê have agreed to join our international panel to contribute to our current and new programs,” said Dr. Lakshmi Kotra, CEO of Lucid Psycheceuticals, a wholly owned subsidiary of FSD Pharma.
  • Dr. Chataway received his Bachelor of Medicine & Surgery from Oxford University, and Doctor of Philosophy from Cambridge University.